Shift Bioscience
Shift Bioscience uses generative AI models to understand how gene activation can reverse aging. This research aims to design more effective drugs for age-related diseases by leveraging cellular reprogramming with Yamanaka factors. The startup is building a cell simulation platform combining generative AI with a biological aging clock to predict and test genes for safe cell rejuvenation.
Funding Round: Seed
Funding Amount: £12.5M
Date: 16-Oct-2024
Investors: BGF, F-Prime Capital, Kindred Capital, Jonathan Milner
Markets: Biotech, AI, Healthtech
HQ: Cambridge, Cambridgeshire, United Kingdom
Founded: 2017
Website: https://www.shiftbioscience.com/
LinkedIn: https://uk.linkedin.com/company/shiftbioscience
Twitter: https://twitter.com/shiftbioscience
Crunchbase: https://www.crunchbase.com/organization/shift-bioscience
Leave a Comment
Comments
No comments yet.